The FGF family: biology, pathophysiology and therapy

被引：1508

作者：

Beenken, Andrew ^{[1
]}

Mohammadi, Moosa ^{[1
]}

机构：

[1] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA

来源：

NATURE REVIEWS DRUG DISCOVERY | 2009年 / 8卷 / 03期

关键词：

FIBROBLAST-GROWTH-FACTOR; BILE-ACID SYNTHESIS; DOMINANT HYPOPHOSPHATEMIC RICKETS; ENDOTHELIAL-CELL PROLIFERATION; ACTIVATED-RECEPTOR-GAMMA; CHRONIC KIDNEY-DISEASE; SPINAL-CORD REPAIR; PHASE-II TRIAL; AUTOSOMAL-DOMINANT; MULTIPLE-MYELOMA;

D O I：

10.1038/nrd2792

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

The family of fibroblast growth factors (FGFs) regulates a plethora of developmental processes, including brain patterning, branching morphogenesis and limb development. Several mitogenic, cytoprotective and angiogenic therapeutic applications of FGFs are already being explored, and the recent discovery of the crucial roles of the endocrine-acting FGF19 subfamily in bile acid, glucose and phosphate homeostasis has sparked renewed interest in the pharmacological potential of this family. This Review discusses traditional applications of recombinant FGFs and small-molecule FGF receptor kinase inhibitors in the treatment of cancer and cardiovascular disease and their emerging potential in the treatment of metabolic syndrome and hypophosphataemic diseases.

引用

页码：235 / 253

页数：19

共 278 条

[91] Fibroblast growth factor 1 - A key regulator of human adipogenesis [J].

Hutley, L ;

Shurety, W ;

Newell, F ;

McGeary, R ;

Pelton, N ;

Grant, J ;

Herington, A ;

Cameron, D ;

Whitehead, J ;

Prins, J .

DIABETES, 2004, 53 (12) :3097-3106

[92] Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization [J].

Ibrahimi, OA ;

Yeh, BK ;

Eliseenkova, AV ;

Zhang, FM ;

Olsen, SK ;

Igarashi, M ;

Aaronson, SA ;

Linhardt, RJ ;

Mohammadi, M .

MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (02) :671-684

[93] Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities [J].

Ibrahimi, OA ;

Zhang, FM ;

Eliseenkova, AV ;

Itoh, N ;

Linhardt, RJ ;

Mohammadi, M .

HUMAN MOLECULAR GENETICS, 2004, 13 (19) :2313-2324

[94] Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome [J].

Ibrahimi, OA ;

Eliseenkova, AV ;

Plotnikov, AN ;

Yu, K ;

Ornitz, DM ;

Mohammadi, M .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (13) :7182-7187

[95]

Ichikawa S., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P318

[96] Induction of FGF-7 after kidney damage: A possible paracrine mechanism for tubule repair [J].

Ichimura, T ;

Finch, PW ;

Zhang, GH ;

Kan, MK ;

Stevens, JL .

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL FLUID AND ELECTROLYTE PHYSIOLOGY, 1996, 271 (05) :F967-F976

[97] FGF-23 in patients with end-stage renal disease on hemodialysis [J].

Imanishi, Y ;

Inaba, M ;

Nakatsuka, K ;

Nagasue, K ;

Okuno, S ;

Yoshihara, A ;

Miura, M ;

Miyauchi, A ;

Kobayashi, K ;

Miki, T ;

Shoji, T ;

Ishimura, E ;

Nishizawa, Y .

KIDNEY INTERNATIONAL, 2004, 65 (05) :1943-1946

[98] Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane [J].

Imura, A ;

Iwano, A ;

Tohyama, O ;

Tsuji, Y ;

Nozaki, K ;

Hashimoto, N ;

Fujimori, T ;

Nabeshima, Y .

FEBS LETTERS, 2004, 565 (1-3) :143-147

[99] α-klotho as a regulator of calcium homeostasis [J].

Imura, Akihiro ;

Tsuji, Yoshihito ;

Murata, Miyahiko ;

Maeda, Ryota ;

Kubota, Koji ;

Iwano, Akiko ;

Obuse, Chikashi ;

Togashi, Kazuya ;

Tominaga, Makoto ;

Kita, Naoko ;

Tomiyama, Ken-ichi ;

Iijima, Junko ;

Nabeshima, Yoko ;

Fujioka, Makio ;

Asato, Ryo ;

Tanaka, Shinzo ;

Kojima, Ken ;

Ito, Juichi ;

Nozaki, Kazuhiko ;

Hashimoto, Nobuo ;

Ito, Tetsufumi ;

Nishio, Takeshi ;

Uchiyama, Takashi ;

Fujimori, Toshihiko ;

Nabeshima, Yo-ichi .

SCIENCE, 2007, 316 (5831) :1615-1618

[100] Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis [J].

Inagaki, T ;

Choi, M ;

Moschetta, A ;

Peng, L ;

Cummins, CL ;

McDonald, JG ;

Luo, G ;

Jones, SA ;

Goodwin, B ;

Richardson, JA ;

Gerard, RD ;

Repa, JJ ;

Mangelsdorf, DJ ;

Kliewer, SA .

CELL METABOLISM, 2005, 2 (04) :217-225

← 5 6 7 8 9 10 11 12 13 14 →